Updating on the pathogenesis of systemic lupus erythematosus.
暂无分享,去创建一个
P. Meroni | M. Biggioggero | R. Gualtierotti | P. Meroni | R Gualtierotti | M Biggioggero | A E Penatti | P L Meroni | A. Penatti
[1] Thomas Korn,et al. IL-17 and Th17 Cells. , 2009, Annual review of immunology.
[2] G. Tsokos,et al. How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype. , 2008, Trends in immunology.
[3] Yuanjia Tang,et al. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. , 2010, Arthritis and rheumatism.
[4] G. Tsokos,et al. PP2A Dephosphorylates Elf-1 and Determines the Expression of CD3ζ and FcRγ in Human Systemic Lupus Erythematosus T Cells1 , 2008, The Journal of Immunology.
[5] Andreas Radbruch,et al. HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus , 2009, Annals of the rheumatic diseases.
[6] S. Ojeda,et al. Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study , 2009, Annals of the rheumatic diseases.
[7] Y. Shoenfeld,et al. Antiphospholipid syndrome dilemmas still to be solved: 2008 status , 2007, Annals of the rheumatic diseases.
[8] S. Puttonen,et al. Increased absence due to sickness among employees with fibromyalgia , 2006, Annals of the rheumatic diseases.
[9] Alain Saraux,et al. IL-6 Modulates CD5 Expression in B Cells from Patients with Lupus by Regulating DNA Methylation1 , 2009, The Journal of Immunology.
[10] T. Niewold,et al. Genetic regulation of serum cytokines in systemic lupus erythematosus. , 2010, Translational research : the journal of laboratory and clinical medicine.
[11] J. Anolik. B cell biology and dysfunction in SLE. , 2007, Bulletin of the NYU hospital for joint diseases.
[12] D. D'cruz,et al. Acute Viral Infections in Patients With Systemic Lupus Erythematosus: Description of 23 Cases and Review of the Literature , 2008, Medicine.
[13] I. Sanz,et al. B cells as therapeutic targets in SLE , 2010, Nature Reviews Rheumatology.
[14] B. Diamond,et al. Phenotypic Characterization of Autoreactive B Cells—Checkpoints of B Cell Tolerance in Patients with Systemic Lupus Erythematosus , 2009, PloS one.
[15] S. Muller,et al. Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. , 2010, Journal of autoimmunity.
[16] Maria Kavai,et al. Immune complex clearance by complement receptor type 1 in SLE. , 2008, Autoimmunity reviews.
[17] G. Tsokos,et al. Systemic lupus erythematosus: new molecular targets , 2007, Annals of the rheumatic diseases.
[18] R. Nurieva,et al. Bcl6 Mediates the Development of T Follicular Helper Cells , 2009, Science.
[19] K. Shokat,et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR , 2008, Proceedings of the National Academy of Sciences.
[20] I. Sanz,et al. Altered B cell receptor signaling in human systemic lupus erythematosus. , 2009, Autoimmunity reviews.
[21] G. Schett,et al. Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE. , 2010, Autoimmunity reviews.
[22] A. Puisieux,et al. Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus , 2009, Nature Immunology.
[23] S. Aslanidis,et al. Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway? , 2008, European journal of internal medicine.
[24] J. Roudier,et al. Epstein-Barr virus in autoimmune diseases. , 2008, Best practice & research. Clinical rheumatology.
[25] L. Truedsson,et al. Analysis of HLA DR, HLA DQ, C4A, FcγRIIa, FcγRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcγRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility , 2004, Arthritis research & therapy.
[26] Kristin G Ardlie,et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. , 2004, American journal of human genetics.
[27] A. Syvänen,et al. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5 , 2008, Human molecular genetics.
[28] Min Chen,et al. The complement system in systemic autoimmune disease. , 2010, Journal of autoimmunity.
[29] J. Ioannidis,et al. The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[30] G. Tsokos,et al. PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells. , 2008, Journal of immunology.
[31] L. Rönnblom,et al. Cytokines as therapeutic targets in SLE , 2010, Nature Reviews Rheumatology.
[32] Kaleb M. Pauley,et al. Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need? , 2009, Arthritis and rheumatism.
[33] A. Puisieux,et al. Retraction Note: Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus , 2014, Nature Immunology.
[34] P. Lipsky,et al. Identification and Characterization of a Human CD5+ Pre-Naive B Cell Population1 , 2009, The Journal of Immunology.
[35] R. Jonsson,et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans , 2002, Nature Genetics.
[36] J. Harley,et al. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. , 2008, Arthritis and rheumatism.
[37] J. Erikson,et al. ICOS expression by effector T cells influences the ability of regulatory T cells to inhibit anti-chromatin B cell responses in recipient mice. , 2010, Journal of autoimmunity.
[38] M. Oukka,et al. Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys1 , 2008, The Journal of Immunology.
[39] L. Pasquier,et al. Orphanet Journal of Rare Diseases , 2006 .
[40] Y. Shoenfeld,et al. The geoepidemiology of systemic lupus erythematosus. , 2010, Autoimmunity reviews.
[41] B. Richardson,et al. The genetics and epigenetics of autoimmune diseases. , 2009, Journal of autoimmunity.
[42] J. Alcocer-Varela,et al. Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities. , 2009, Autoimmunity reviews.
[43] L. Truedsson,et al. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. , 2010, Blood.
[44] P. von Landenberg,et al. Toll-like receptors and autoimmunity. , 2008, Autoimmunity reviews.
[45] D. Isenberg,et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. , 2010, Immunity.
[46] Geoffrey Hom,et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. , 2008, The New England journal of medicine.
[47] H. Wardemann,et al. Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells. , 2008, Immunity.
[48] L. Peltonen,et al. AIRE regulates T-cell-independent B-cell responses through BAFF , 2008, Proceedings of the National Academy of Sciences.
[49] O. Rekvig,et al. Nuclease deficiencies promote end‐stage lupus nephritis but not nephritogenic autoimmunity in (NZB × NZW) F1 mice , 2011, Immunology and cell biology.
[50] F. Middleton,et al. Activation of Mammalian Target of Rapamycin Controls the Loss of TCRζ in Lupus T Cells through HRES-1/Rab4-Regulated Lysosomal Degradation1 , 2009, The Journal of Immunology.
[51] Igor M. Dozmorov,et al. Identification of Unique MicroRNA Signature Associated with Lupus Nephritis , 2010, PloS one.
[52] C. Grimaldi,et al. Hormonal regulation of B-cell function and systemic lupus erythematosus , 2008, Lupus.
[53] J. Ioannidis,et al. The role of FcγRIIA and IIIA polymorphisms in autoimmune diseases , 2004 .
[54] M. Nambiar,et al. Differential Expression and Molecular Associations of Syk in Systemic Lupus Erythematosus T Cells1 , 2008, The Journal of Immunology.